These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19655191)

  • 1. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.
    Uzawa A; Mori M; Ito M; Uchida T; Hayakawa S; Masuda S; Kuwabara S
    J Neurol; 2009 Dec; 256(12):2082-4. PubMed ID: 19655191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
    Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
    PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
    Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
    Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
    Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
    Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
    Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
    Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
    Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
    Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
    Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A
    Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Sawai S; Kuwabara S
    Clin Chim Acta; 2017 Jun; 469():144-149. PubMed ID: 28283439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.
    Uzawa A; Mori M; Arai K; Sato Y; Hayakawa S; Masuda S; Taniguchi J; Kuwabara S
    Mult Scler; 2010 Dec; 16(12):1443-52. PubMed ID: 20739337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
    Uchida T; Mori M; Uzawa A; Masuda H; Muto M; Ohtani R; Kuwabara S
    Mult Scler; 2017 Jul; 23(8):1072-1084. PubMed ID: 27682231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
    Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.
    Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X
    J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
    Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
    J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity.
    Pei S; Zheng D; Wang Z; Hu X; Pan S; Wang H
    Cytokine; 2018 Nov; 111():140-145. PubMed ID: 30142535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations.
    Bergamaschi R; Tonietti S; Franciotta D; Candeloro E; Tavazzi E; Piccolo G; Romani A; Cosi V
    Mult Scler; 2004 Feb; 10(1):2-4. PubMed ID: 14760945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
    Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks.
    Uzawa A; Mori M; Sawai S; Masuda S; Muto M; Uchida T; Ito S; Nomura F; Kuwabara S
    Clin Chim Acta; 2013 Jun; 421():181-3. PubMed ID: 23535508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.